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Yin Yang 1 Is a Negative Regulator of p53
YY1 in vivo, we ablated YY1 in cultured cells using bothGuangchao Sui,1 El Bachir Affar,1,3
homologous recombination-based gene knockout andYujiang Shi,1,3 Chrystelle Brignone,2
RNA-mediated interference (RNAi) (Fire et al., 1998).Nathan R. Wall,1 Peng Yin,1 Mary Donohoe,1
These studies have led to the discovery of a previouslyMargaret P. Luke,1 Dominica Calvo,1
unsuspected connection between YY1, Hdm2, and p53Steven R. Grossman,2 and Yang Shi1,*
and a crucial role for YY1 in p53 regulation (see below).1Department of Pathology
p53 is a tumor suppressor protein and a transcrip-Harvard Medical School
tional regulator that plays an important role in cellular77 Avenue Louis Pasteur
responses to various stress signals (reviewed in LevineBoston, Massachusetts 02115
[1997] and Ryan et al. [2001]). p53 protein is drastically2 Departments of Cancer Biology and Medicine
induced under conditions such as DNA damage. TheUniversity of Massachusetts Medical School
rise in p53 either activates transcription of the cell cycleWorcester, Massachusetts 01605
regulator p21, which induces cell growth arrest, or the
proapoptotic gene bax, which induces apoptosis (re-
viewed in Oren [2003]). Similarly, p53 is also induced inSummary
response to oncogenic insults, and activation of p53
is an important mechanism that helps prevent tumorYin Yang 1 (YY1) is a transcription factor that plays
development (reviewed in Sherr and Weber [2000] andan essential role in development. However, the full
Lowe [1999]). The importance of p53 as a tumor sup-spectrum of YY1’s functions and mechanism of action
pressor is highlighted by the fact that over 50% of allremains unclear. We find that YY1 ablation results in
tumors carry inactivating mutations in p53 gene (re-p53 accumulation due to a reduction of p53 ubiquitina-
viewed in Lane [1994]).tion in vivo. Conversely, YY1 overexpression stimu-
p53 is regulated primarily at the level of protein stabil-lates p53 ubiquitination and degradation. Significantly,
ity by its interacting partner, the mouse double minute 2recombinant YY1 is sufficient to induce Hdm2-medi-
protein (Mdm2, or Hdm2 for the human ortholog). Mdm2-ated p53 polyubiquitination in vitro, suggesting that
deficient mice die during early embryogenesis. Thisthis function of YY1 is independent of its transcrip-
early lethal phenotype can be suppressed completelytional activity. We identify direct physical interactions
by simultaneous inactivation of p53, suggesting that theof YY1 with Hdm2 and p53 and show that the basis
main function of Mdm2 in vivo is to regulate p53 (Jonesfor YY1-regulating p53 ubiquitination is its ability to
et al., 1995; Montes de Oca Luna et al., 1995). At thefacilitate Hdm2-p53 interaction. Importantly, the tumor
molecular level, Mdm2 functions as an E3 ubiquitin li-suppressor p14ARF compromises the Hdm2-YY1 inter-
gase, which mediates p53 ubiquitination and proteaso-action, which is important for YY1 regulation of p53.
mal degradation in vivo (Honda et al., 1997). Thus, fac-Taken together, these findings identify YY1 as a poten-
tors that regulate the physical interaction of Mdm2 withtial cofactor for Hdm2 in the regulation of p53 homeo-
p53 or Mdm2 activity will directly impact the p53 steady-stasis and suggest a possible role for YY1 in tumori-
state level in the cell. For instance, posttranslationalgenesis.
modifications such as phosphorylation and acetylation
of p53 have been shown to regulate p53 stability in partIntroduction
by controlling the accessibility of p53 to Mdm2 (Ito et
al., 2002; Prives, 1998). Likewise, multiple mechanisms
Yin Yang 1 (YY1) is a multifunctional transcription factor
may also be in place to modulate Mdm2 activity and/or
that can act as a transcriptional repressor, activator, or
its ability to access p53 for ubiquitination. For instance,
initiator element binding protein (reviewed in Shi et al. the tumor suppressor p14ARF (p19ARF in mouse) directly
[1996] and Thomas and Seto [1999]). The transcriptional interacts with and functionally inactivates Mdm2, by ei-
activity of YY1 can be regulated by viral oncoproteins ther relocating Mdm2 to the nucleolus and/or forming a
such as adenovirus E1A, suggesting a possible role for tripartite complex with Mdm2 and p53, which abrogates
YY1 in cell proliferation (Shi et al., 1991). Consistent with Mdm2 regulation of p53 (reviewed in Sherr and Weber
this hypothesis, previous studies identified a myriad of [2000] and Zhang and Xiong [2001]). Similarly, the human
potential YY1 target genes whose products are impor- ribosomal protein L11 can also interact with Hdm2 and
tant for proliferation and differentiation (reviewed in Shi participate in Hdm2 relocalization to the nucleolus (Loh-
et al. [1996] and Thomas and Seto [1999]). Furthermore, rum et al., 2003). Recently, cyclin G has been shown to
YY1/ mouse embryos die during early embryogenesis regulate p53 level through modulation of Hdm2 via the
at around the time of implantation, which is a develop- associated phosphatase PP2A (Okamoto et al., 2002).
mental stage characterized by rapid cell proliferation Taken together, these findings suggest that both p53
and differentiation (Donohoe et al., 1999). However, the and Hdm2 can be subjected to multiple levels of regula-
exact cellular functions of YY1 remained unclear. To tion, which affect the intracellular level of p53.
further investigate the role and mechanism of action of In this study, we found that loss of YY1 results in a
significant increase in p53 level. Conversely, overex-
pression of YY1 significantly decreased endogenous*Correspondence: yang_shi@hms.harvard.edu
3 These authors contributed equally to this work. p53 level. Multiple lines of evidence suggest that YY1
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Figure 1. Generation of a Targeted Mutation at the cyy1 Locus in DT40 Cells and the Characterization of the cyy1 Nullizygous Cells
(A) Genomic organization of the cyy1 locus and design of the targeting constructs. For the knockin/knockout step, a 4.9 kb BamHI/EcoRV
fragment containing cyy1’s entire exon I and its2 kb promoter region was replaced by the neo R expression cassette and the cyy1 transgene
driven by tet-repressive promoter (t-cyy1). The second knockout step replaces the entire exon I plus a few hundred base pairs of the proximal
promoter of cyy1. External probes P1 and P2 were used to identify homologous recombination by Southern blot. B, BamHI; Ev, EcoRV.
(B) Identification of DT40 cells containing different cyy1 alleles. Probe P1 was hybridized to the BamHI digested genomic DNA from wt and
mutant DT40 cells (genotypes indicated at the top), and genotypes were confirmed by probe P2 (data not shown).
(C) cYY1 and cp53 expression in the presence of tet. Aliquots of cyy1 nullizygous cells (/t-cyy1) grown in the medium with 0.5 g/ml of tet
over a period of 72 hr were collected. Whole cell lysates were analyzed by Western blotting using YY1 (top panel), p53 (middle panel), and 
actin (bottom panel) antibodies.
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directly regulates the ability of Hdm2 to ubiquitinate p53 isolated cyy1 heterozygous cells (Supplemental Figure
S1C). We then attempted to mutate the second cyy1through protein-protein interactions. These include the
findings that YY1 physically interacts with Hdm2 and p53 allele without success, although we observed homolo-
gous recombination between the targeting vector andand that wild-type (wt) YY1 but not an Hdm2 binding-
defective mutant stimulates Hdm2-mediated p53 ubi- the mutant cyy1 allele (data not shown), suggesting that
lack of cYY1 is likely to be cell lethal.quitination both in vivo and in vitro using purified protein
components. We further demonstrate that this YY1 regu- To obtain a cyy1 null cell line, we turned to a knockin/
knockout strategy, outlined in Figure 1A. Essentially,lation of Hdm2-p53 is likely to be the result of the ability
of YY1 to promote Hdm2-p53 physical interaction, which exon I of cyy1 was first replaced by a tet-regulatable
(tet-off) cyy1 transgene, referred to as t-cyy1 (Figure 1A,is a prerequisite for Hdm2 regulation of p53 ubiquitina-
tion. Consistently, we found a reduction of Hdm2-p53 “1st step,” and Figure 1B, lane 2). The combined cYY1
expression from the remaining wt and the t-cyy1 allelesinteraction upon reduction of YY1 protein level. Signifi-
cantly, p14ARF also interacts with YY1 and can disrupt upon induction was comparable to that of the wt DT40
cells (data not shown). Under the tet-off condition inthe Hdm2-YY1 interaction, which is important for YY1
regulation of Hdm2-mediated p53 ubiquitination. Taken which the cyy1 transgene was induced, we successfully
mutated the remaining wt cyy1 allele (Figure 1B, lane 3)together, our findings identify YY1 as a potential cofac-
tor for Hdm2 and support the model that YY1 plays an using the constitutive cyy1 knockout vector depicted in
Figure 1A (“2nd step”).important role in Hdm2-mediated p53 ubiquitination and
degradation. These findings not only provide important
insights into YY1 function but also shed light on the Loss of YY1 Leads to an Increase in p53 Level
increasingly complex regulation of Hdm2-mediated p53 and DT40 Cell Apoptosis
ubiquitination that may be important for understand- As shown in Figure 1C, upon tet addition, ectopically
ing tumorigenesis. provided cYY1 was significantly depleted by 24 hr and
was undetectable by 48 hr (top panel). As a conse-
quence, growth of these cells was significantly compro-Results
mised (Figure 1E, /t-cyy1, tet). We analyzed a total
of three independently isolated cell lines and obtainedGenetic Ablation of YY1 in Chicken DT40 Cells
Chicken B lymphoma DT40 cells support efficient ho- the same results. Interestingly, the cyy1 heterozygous
cells (/and/t-cyy1 [tet]) also displayed significantmologous recombination and thus are well suited for
gene function studies through targeted gene disruption growth retardation (Figure 1E, /c-yy1, tet; and see
Supplemental Figure S2 at Cell web site). The growth(Buerstedde and Takeda, 1991). To knock out yy1 in
DT40 cells, we isolated a full-length chicken yy1 cDNA potential of these heterozygous cells can be restored
close to the wt level by turning on cyy1 transgene ex-(cyy1), which shares 88% amino acid similarity with that
of human YY1 (hYY1) (see Supplemental Figure S1A at pression (Figure 1E, compare /t-cyy1 [tet] with
/t-cyy1), suggesting that YY1 dosage may be impor-http://www.cell.com/cgi/content/full/117/7/859/DC1).
The C-terminal half of cYY1, which includes the four tant for cell proliferation. To determine the basis of this
growth defect, we analyzed the cyy1 null cells by FACS.zinc fingers, is identical to that of hYY1, suggesting
that cYY1 and hYY1 recognize the same DNA sequence As shown in Figure 1F, upon tet addition, the sub G1
cell population continued to accumulate in the cyy1 nulli-elements. We next isolated a cyy1 genomic fragment
that contains the promoter as well as the entire exon I, zygous but not in wt cells, coinciding with the depletion
of the cYY1 proteins in the cell. This suggested that cellswhich represents 55% of the cyy1 coding region. Using
this genomic fragment, we generated a targeting vector, lacking cYY1 may be undergoing apoptosis. Consistent
with this, we found caspase activation in a time coursewhich is essentially the same as the yy1 mouse knockout
construct described earlier (Donohoe et al., 1999) (Sup- that paralleled cYY1 decrease and the onset of apopto-
sis (Figure 1G). By day 5, the majority of the YY1-nega-plemental Figure S1B). Replacement of the wt allele with
this targeting vector is predicted to generate a cyy1 null tive cells were disintegrated, which may account for the
decrease in the caspase activity at this time point (Figureallele (Donohoe et al., 1999). Using this strategy, we first
(D) YY1 depletion induces bax transcription in DT40 cells. The DT40 cyy1 nullizygous cells (/t-cyy1) were collected at the different time
points post tet addition for mRNA preparation. Semiquantitative RT-PCR was performed to detect expression of cbax and c actin. The
sequences of the oligos used in RT-PCR are the following: cbax, 5-CAGAAGGCGGAGGACCTCGTGAAG-3 and 5-ACAGCCTTGTGCTTCCG
CAGCCACC-3; and c actin, 5-CTGCGCTCGTTGTTGACAATGGCTC-3 and 5-GTAGCCTTCATAGATGGGCACAGTG -3.
(E) Proliferation of wt, cyy1 heterozygous, and nullizygous cells. Wt DT40, /t-cyy1, and /t-cyy1 cells (triplicate samples) were analyzed for
the presence of live cells using trypan blue every 12 hr over a period of 5 days in the presence and absence of tet, with the starting cell
density at 20,000 cells/ml. The proliferation curves were obtained by plotting cell density over time with standard deviation.
(F) FACS analysis of wt and cyy1 nullizygous cells (/t-cyy1). Wt DT40 and /t-cyy1 cells were grown in the absence or the presence of tet.
Every 24 hr, aliquots of cells were collected, fixed in 50% ethanol, and stained by propidium iodide before FACS analysis. The percentages
of sub G1 (apoptotic) cells are indicated.
(G) Depletion of cYY1 expression is correlated with an increase in caspase activity. Whole cell lysates prepared from /t-cyy1 cells grown in
the presence of tet over a period of 5 days were assayed for caspase 3 activity. Lysates from cells treated with 10 M etoposide were used
as a positive control.
(H) DNA laddering in DT40 cells depleted of YY1. Wt DT40 (/) and the cyy1 nullizygous (/t-cyy1) cells were grown in the presence or
absence of tet for 5 days before the cells were collected. Genomic DNA was prepared and analyzed on a 1.5% agarose gel.
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1G). Furthermore, DNA isolated from these cells dis-
played internucleosomal DNA degradation characteris-
tic of apoptotic cells (Figure 1H). Taken together, these
findings showed that DT40 cells undergo apoptosis in
the absence of cYY1.
The tumor suppressor p53 plays an essential role in
cell growth arrest and apoptosis in response to DNA
damage or oncogenic insult (Levine, 1997). We asked
whether removal of cYY1 may have affected p53 regula-
tion. As shown in Figure 1C, the gradual depletion of
cYY1 upon tet addition was paralleled by p53 (cp53)
accumulation. Significantly, transcription of the apo-
ptotic gene bax, which is a downstream target of p53
(Miyashita and Reed, 1995), was also activated in a time
course that parallels cp53 accumulation (Figure 1D),
suggesting that cp53 is likely to be functional in DT40
cells. p53 expression in DT40 cells has been a controver-
sial issue, with two published studies reporting opposite
results (Takao et al., 1999; Tanikawa et al., 2001). In
addition to the Western blotting result (Figure 1C), we
were able to detect and subclone p53 mRNA from DT40
cells by RT-PCR, thus providing unequivocal evidence
demonstrating p53 expression in DT40 cells (our unpub-
lished data). Taken together, these findings identify a
previously unsuspected role for cYY1 in regulating p53
protein level in vivo. This regulation is not unique to
DT40 cells, because we also observed a similar increase
in p53 protein level and its downstream target genes
p21, bax, and gadd45 in mammalian cells upon depletion
of YY1 by RNAi (Figures 2A and 2B). As expected, the
p53 mRNA level remained unchanged, but mRNA levels
of p21, bax, and gadd45 were increased (Supplemental
Figure S3), which could account for the rise of p21, Bax,
Figure 2. YY1 Regulation of p53 in Mammalian Cellsand GADD45 at the protein levels. Significantly, global
(A and B) Expression of YY1, p53, and p53 target genes in yy1profiling of YY1 target genes identified a large number
knockdown cells. Cells were either infected with retrovirus con-of p53 target genes whose expression is affected by
taining U6/gfp or U6/yy1 siRNA DNA templates (U2OS) (A) or trans-the loss of YY1 (our unpublished data), suggesting that
fected with pBS/U6/gfp or pBS/U6/yy1 siRNA plasmids (MCF-7)YY1 plays a critical and widespread role in regulating
(B). Four days after infection or transfection, total cell lysates were
p53 target gene expression. The functional conse- analyzed by Western blot using the antibodies indicated on the left.
quence of YY1 knockdown was further analyzed by (C) YY1 depletion causes cell growth retardation. U2OS cells were
RNAi. As shown in Figure 2C, the number of puromycin- transfected with pBS/U6/gfp or pBS/U6/yy1 siRNA plasmids con-
taining the puromycin expression cassette and selected with 1.0resistant colonies was significantly reduced as a result
g/ml of puromycin for about 10 days. The foci were detected withof YY1 depletion, suggesting that YY1 is essential for
crystal violet, and the numbers were the average of four (control)U2OS cell growth. Taken together, these findings sug-
or six (yy1) independently transfected plates.gest that YY1 regulation of p53 is conserved in mamma-
lian cells and that depletion of YY1 can result in either
apoptosis or growth suppression.
of motifs, including the bipartite acidic regions at the NSince YY1 can function as a transcriptional repressor
terminus, the histidine cluster, the glycine/alanine (G/A)-(Shi et al., 1991), we next asked if the increase in cp53
and the glycine/lysine (G/K)-rich regions, and the spacerlevel in the absence of cYY1 was due to an increase in
region, which contains an element that is uniquely con-cp53 mRNA. Northern blot analysis found comparable
served from Drosophila to human (reviewed in Thomascp53 mRNA levels in the presence and absence of cYY1
and Seto [1999]). While the acidic regions are important(Supplemental Figure S4), suggesting that regulation of
for transcriptional activation (Bushmeyer et al., 1996;cp53 by cYY1 is not at the level of cp53 transcription
Lee et al., 1995b), the G/K region binds histone deacet-or RNA processing. In addition, c-myc, a known activa-
ylases and is important for YY1 repression functiontor of p53, is only modestly affected if at all (Supplemen-
(Yang et al., 1996). We analyzed cYY1 mutants carryingtal Figure S4). As discussed below, the effect of YY1 on
these various deletions for their ability to rescue cYY1-p53 (stimulation of ubiquitination) appears to be separa-
depleted DT40 cells. As shown in Figure 3, wt cYY1ble from YY1’s transcriptional activities and may be me-
restored growth assayed by the colony numbers, indi-diated by direct protein-protein interactions.
cating that apoptosis observed in DT40 cells is a resultTo investigate mechanisms by which YY1 regulates
of cYY1 depletion. Importantly, deletions that removedDT40 apoptosis, we first carried out genetic rescue ex-
the HDAC-interacting or the acidic domains of cYY1periments to identify domains of YY1 that are important
for YY1 function in DT40 cells. YY1 contains a number had only a mild effect on the rescuing ability of cYY1,
Direct Regulation of p53 Ubiquitination by YY1
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Figure 3. Genetic Rescue Experiments in DT40 Cells
Wt and deletion mutants of chicken yy1 driven by the endogenous chicken yy1 promoter were individually transfected into cyy1 nullizygous
cells (/t-cyy1). After 2 days, the cells were plated to 96-well plates in the medium containing 1.0 g/ml of tet to suppress cyy1 expression
from the t-cyy1 allele. Cell colonies were counted 2 weeks later. Results from two independent experiments and the average are shown.
consistent with the hypothesis that individual transcrip- AdaAhx3L3VS (Ada, [Kessler et al., 2001]) (Figure 4C,
compare lane 6 with lane 3). These experiments suggesttional activities may not be essential for this biological
that YY1 interacts with both Hdm2 and p53 in vivo. Thefunction of YY1 (Figure 3). Deletion of the histidine clus-
interactions of YY1 with Hdm2 and p53 are likely to beter had a significant impact on the rescuing ability, but
direct, since these interactions can be recapitulated withthe basis for this defect remains to be determined. How-
bacterially purified proteins in vitro (Figures 4D–4G).ever, removal of the spacer region (205–299) essen-
To better understand the interactions among YY1,tially abrogated the ability of cYY1 to rescue (Figure 3).
Hdm2, and p53, we carried out in vitro binding experi-Control experiments indicate that all the cYY1 mutants
ments to identify domains involved in the interactions.tested can be expressed at comparable levels (data not
As shown in Figures 4D and 4E, amino acids (aa) 150–290shown). As will be discussed later, this region of YY1
of Hdm2 and the C-terminal region of p53 (aa 290–393)appears to be necessary for the physical interaction with
are important for the direct interactions with YY1, re-Hdm2 and for regulating p53 ubiquitination.
spectively. Previous studies showed that the N-terminal
regions of Hdm2 and p53 are involved in direct physical
YY1 Physically Interacts with Hdm2 interactions with one another (Chen et al., 1993), which
and p53 In Vivo and In Vitro are distinct from the domains that mediate their interac-
p53 is controlled primarily by Mdm2-mediated ubiquiti- tions with YY1. We also investigated domains within
nation and degradation by the proteasome. Recent YY1 that interact with p53 and Hdm2. Two regions in
studies suggest that additional proteins may regulate YY1 (aa 142–224 and aa 331–414) appear to interact
Mdm2-mediated p53 ubiquitination (Cummings et al., with p53 (Figure 4F). We next analyzed the interaction
2004; Grossman et al., 2003; Kamijo et al., 1998; Li et between Hdm2 and YY1. As shown in Figure 4G, the
al., 2004; Lohrum et al., 2003; Okamoto et al., 2002; human YY1 spacer deletion mutant (200–295), which
Pomerantz et al., 1998; Zhang et al., 1998). Given that is equivalent to the chicken mutant (205–299) defective
p53 protein level is inversely correlated with that of YY1 in the rescue experiment (Figure 3), displayed a greatly
and that p53 RNA level appears unaffected by YY1 reduced ability to interact with Hdm2 (compare lane 7
depletion, we asked whether YY1 plays a role in regulat- with lane 3). However, this mutant interacted with p53
ing Hdm2-mediated p53 ubiquitination in vivo through (Figure 4G, compare lane 8 with lane 4) and can repress
protein-protein interactions. We first investigated transcription (Supplemental Figure S5), similar to wt
whether YY1 physically interacts with Hdm2 and p53. YY1. Thus, the reduced ability to interact with Hdm2 is
As shown in Figure 4A, a YY1 but not two unrelated unlikely to be due to a gross structural alteration. Taken
antibodies coimmunoprecipitated (CoIP) Hdm2 (com- together, these findings identify nonoverlapping do-
pare lane 4 with lanes 2 and 3). Likewise, reciprocal mains involved in YY1, Hdm2, and p53 interactions,
CoIP with an Hdm2 but not the unrelated antibodies strongly suggesting that these three proteins can form
also pulled down YY1 (Figure 4B, compare lane 4 with a ternary complex. To test this hypothesis, we subjected
lanes 2 and 3), suggesting an interaction between en- bacterially purified YY1, Hdm2, and p53 to glycerol gra-
dogenous YY1 and Hdm2. Similarly, we also detected dient centrifugation. As shown in Supplemental Figure
a weak endogenous YY1-p53 interaction in U2OS cells, S6, only when all three proteins were present did we
which was significantly enhanced when p53 level was observe the appearance of YY1, Hdm2, and p53 simulta-
neously in high molecular weight factions (MW greaterraised with the treatment of the proteasome inhibitor
Cell
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Figure 4. YY1 Interacts with Both Hdm2 and p53
(A) YY1 interacts with Hdm2 in vivo. Total U2OS cell lysates were immunoprecipitated with Hdm2 (N-20), GFP, or -gal polyclonal antibodies.
The immunoprecipitates were analyzed by Western blot using a YY1 monoclonal antibody (H-10).
(B) Reciprocal IP confirms YY1 and Hdm2 interaction in vivo. Total U2OS cell lysates were immunoprecipitated with YY1 polyclonal (H-414)
and two control antibodies, respectively, followed by Western blot analysis using a Hdm2 antibody (Smp-14).
(C) YY1 and p53 interact in vivo. U2OS cells were either untreated or treated with 10 M of Ada (Kessler et al., 2001) for 6 hr. Cell lysates
Direct Regulation of p53 Ubiquitination by YY1
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than 150 KD; Figures S6d, S6g, and S6j, fractions 31–37), strate degradation by the proteasome (Pickart, 1997).
We compared YY1-stimulated p53 polyubiquitinationsuggesting a possible ternary or higher order complex.
Although the stoichiometry remains to be determined, using either wt or the K48R (arginine) mutant Ub. As
shown in Figure 5D, the ability of YY1 to stimulate p53these findings, together with the domain mapping infor-
mation, support the model that YY1, Hdm2, and p53 can polyubiquitination was significantly compromised using
the mutant Ub (K48R), suggesting that YY1-stimulatedform ternary or higher order complexes (Figure 4H).
p53 polyubiquitination occurred predominantly on K48
of the Ub moiety (compare lanes 5 and 6 with lanes 2YY1 Can Stimulate Hdm2-Mediated p53
Polyubiquitination and Degradation and 3). We confirmed that these slower-migrating moie-
ties are polyubiquitinated p53 by reprobing the sameWe next investigated the possibility that YY1 may di-
rectly regulate p53 ubiquitination and proteasome- blot with a p53 monoclonal antibody (Figure 5D, middle
panel). These findings support the model that YY1 playsmediated degradation. As shown in Figure 5B, YY1
downregulation by RNAi significantly reduced endoge- an important role in p53 ubiquitination and degradation
by the proteasome.nous p53 polyubiquitination in a human diploid fibro-
blast cell line (WI-38) (compare lane 2 with lane 1), We next determined whether YY1 stimulation of p53
ubiquitination is mediated by Hdm2 in vivo. YY1, p53,suggesting that YY1 is required for efficient p53 ubiquiti-
nation in vivo. In contrast to YY1 depletion, YY1 overex- and HA-tagged Ub together with either wt or a catalyti-
cally inactive Hdm2 were transfected into p53//pression led to an enhanced endogenous p53 ubiquiti-
nation in the presence of the proteasome inhibitor Ada mdm2/ mouse embryonic fibroblast (MEF) cells. As
shown in Figure 5E, YY1 overexpression alone had very(Figure 5B, compare lane 5 with lane 4). Consistently,
in the absence of Ada, overexpression of YY1 resulted little effect on p53 ubiquitination (compare lanes 3 and
4 with lane 2). In contrast, YY1 significantly enhancedin a significant reduction of the p53 steady-state level
(Figure 5C, middle panel, compare lanes 4–6 with lane p53 ubiquitination in the presence of transfected wt but
not the catalytically inactive Hdm2 (Figure 5E, compare1). Given that YY1 is a transcription factor, we asked
whether this effect of YY1 on p53 ubiquitination was lanes 6 and 7 with lane 5 and with lanes 8 and 9). Taken
together, these findings argue strongly that YY1 stimu-linked to its ability to regulate transcription. We analyzed
a YY1 chimeric protein (Chi17), in which zinc finger 2 lates p53 ubiquitination through Hdm2 and provide a
possible molecular explanation for the increase in p53was replaced by a similar C2H2-type finger from GFI-1
(Figure 5A and Galvin and Shi [1997]). Chi17 is unable level observed in the YY1 nullizygous cells.
to bind YY1 consensus sequences or to repress tran-
scription as a GAL4 fusion protein (Galvin and Shi, 1997). YY1 Stimulates p53 Polyubiquitination
in an In Vitro Ubiquitination SystemHowever, similar to wt YY1, Chi17 can interact with
Hdm2 and p53 (Supplemental Figure S7) and stimulate To seek further evidence that YY1 regulates Hdm2-
mediated p53 ubiquitination via direct physical interac-p53 ubiquitination (Figure 5B, lane 6). Taken together,
these findings suggest that the ability of YY1 to stimulate tion, we asked whether recombinant YY1 protein can
stimulate Hdm2-mediated p53 ubiquitination in vitro us-p53 ubiquitination is likely to be independent of YY1
target gene regulation. Supporting this model, the YY1 ing purified Hdm2 and p53 (Grossman et al., 2003). It
has been suggested that Mdm2 mainly mediates mono-spacer deletion mutant (200–295), which is inactive in
the genetic rescue experiments (Figure 3) and defective ubiquitination of p53 in vitro (Grossman et al., 2003; Lai
et al., 2001; Li et al., 2003). As shown in Figure 6A,for crucial protein interactions with Hdm2 (Figure 4G),
was compromised in its ability to stimulate p53 ubiquiti- bacterially purified His-YY1 stimulated the production
of slower-migrating p53 (lane 2), while a mock-purifiednation (Figure 5B, compare lane 7 with lane 5).
Ubiquitin (Ub) chain extension can occur on a number fraction did not (lane 1). These slower-migrating p53
proteins are likely to be polyubiquitinated p53 species,of different lysine (K) residues on the Ub molecule, but
only chain polymerization at K48 is important for sub- because the use of methylated Ub, which does not sup-
were immunoprecipitated with GFP (FL) and YY1 (H-414) antibodies and analyzed by Western blot using a p53 antibody (DO-1).
(D) Identification of Hdm2 domain that interacts with YY1. GST-Hdm2 fusion proteins were diagrammed in the top panel. Purified GST-Hdm2
proteins (3 g each) were individually incubated with purified His-YY1 (1.5 g) and Western blotted using a His epitope antibody (H-3). The
results of the GST pulldown experiment are summarized on the right of the top panel. The domains identified to be necessary for the physical
interaction are indicated on the top. The input GST proteins are shown in the bottom panel.
(E) Identification of p53 domains that interact with YY1. Wt and mutant GST-p53 fusion proteins are diagramed in the top panel. Interactions
of His-YY1 with various GST-p53 fusion proteins were analyzed by GST pulldown assays (middle panel). The input GST fusion proteins are
shown in the bottom panel. The results are summarized on the right, and the interacting domains for Hdm2 and YY1 are indicated on the top.
(F) Identification of YY1 domains that interact with p53. GST-YY1 fusion proteins are diagramed in the top panel. The purified GST-YY1 proteins
(3 g each) were incubated with in vitro translated, 35S-labeled p53 followed by SDS-PAGE analysis. The autoradiography of the bound 35S-p53
and the Coomassie blue staining of the gel are shown in the middle and the bottom panels, respectively. The results are summarized on the
right, and the binding sites for p53 and Hdm2 are indicated at the top.
(G) YY1 interacts with Hdm2 and p53 in vitro. Equal amounts (3 g) of purified GST, GST-Hdm2, or GST-p53 were incubated with purified
His-YY1 or His-YY1 (200–295) (1.5 g each) at 4C for 4 hr. After extensive washing, the samples were analyzed by Western blot using the
His epitope antibody.
(H) Schematic diagram of the YY1-Hdm2-p53 ternary complex. The N-terminal regions of Hdm2 and p53 are involved in their interaction with
one another (Chen et al., 1993). Two regions of YY1 (middle and C-terminal) can interact with the C-terminal region of p53. A middle,
nonoverlapping region of YY1 interacts with Hdm2.
Cell
866
Figure 5. YY1 Is Necessary for Optimal Hdm2-Mediated p53 Ubiquitination and Degradation In Vivo
(A) Schematic diagrams of wt, YY1 chimera 17 (Chi17), and the spacer deletion mutant. The four zinc fingers at the C terminus are boxed.
The zinc finger from GFI-1 is indicated by a solid box. Their binding ability to YY1 consensus sites and the repression activity are indicated
by the plus and minus signs. N/D, not determined.
(B) Endogenous p53 ubiquitination is regulated by YY1. WI-38 cells were either infected by retroviruses containing an U6/gfp or U6/yy1 siRNA
(lanes 1 and 2) or transfected by pcDNA3 vector alone (lanes 3 and 4) and HA-tagged wt YY1, Chi17, or YY1 (200–295) (lanes 5–7). Cells were
grown in medium containing 2.5M of Ada for 3 days (lanes 1 and 2) or 5.0M Ada for 24 hr (lanes 4–7). Cell lysates were immunoprecipitated with
a p53 antibody and Western blotted with a Ub antibody (MAB1510, Chemicon). The direct Western blots for YY1, Hdm2, p53, and cotransfected
Direct Regulation of p53 Ubiquitination by YY1
867
Figure 6. YY1 Stimulates p53 Polyubiquitination In Vitro
(A) YY1 stimulates p53 ubiquitination using native but not methylated Ub. In vitro ubiquitination assays were performed in the presence of
purified HA-p53, purified FLAG-Hdm2 (E3), E1, UbcH5a (E2), and ATP. p53 polyubiquitination in the presence of Ub (compare lanes 1 and 2)
or methylated Ub (Me-Ub) (compare lanes 3 and 4) was determined in the presence or absence of His-YY1. Lane 5 is the positive control for
polyubiquitination (Grossman et al., 2003). The reaction mix was analyzed by Western blot using a p53 antibody (DO-1).
(B) YY1 stimulation of p53 polyubiquitination requires E1, E2, and E3 (Hdm2). In vitro p53 ubiquitination assays were performed in the presence
of E1, UbcH5a (E2), and Hdm2 (E3) without (lane 1) or with His-YY1 (lanes 2–5, 100 ng), followed by p53 immunoblotting. Hdm2, UbcH5a (E2),
or E1 were respectively omitted in lanes 3–5. The blot was relatively underexposed to better highlight the region where monoubiquitination
would be observed. p53 immunoreactive signal is absent in the 61–100 kDa range within lanes 3–5 where monoubiquitinated p53 species
would appear (Grossman et al., 2003), indicating that YY1 cannot substitute for E1, E2, or Hdm2 (E3) functions for the ubiquitination of p53.
Mono- and polyubiquitinated p53 are indicated on the right. Asterisk indicates a covalent dimer (nonubiquitinated) form of purified p53 seen
when purified p53 is incubated at 37C (Grossman et al., 2003).
(C) Wt His-YY1 but not His-YY1 (200–295) stimulates p53 polyubiquitination through K48 of Ub. In vitro ubiquitination assays were performed
as described above in the presence of Ub (lanes 1–7) or Ub (K48R) (lanes 8–10) at 37C for 30 min in the absence or presence of either wt or
mutant YY1 (200–295) as indicated on the top. The reaction mixes were analyzed by Western blot using a p53 antibody.
port Ub chain polymerization, blocked their formation sence of transcription, and this regulation is likely to be
mediated by direct physical interactions. The ability of(Figure 6A, lane 4). Incubation of YY1 with p53 alone in
the absence of E1, UbcH5a (E2), or Hdm2 (E3) had no YY1 to stimulate p53 polyubiquitination in vitro suggests
that YY1 may function either as a cofactor for Hdm2 oreffect (Figure 6B). Furthermore, the K48R Ub failed to
support YY1 stimulation of p53 polyubiquitination (Fig- may itself have an intrinsic enzymatic activity (E4 ligase)
that promotes p53 polyubiquitination (Grossman et al.,ure 6C, lanes 8–10). These results are consistent with the
cell culture data (Figures 5D and 5E), providing further 2003). Since YY1 plays an important role in facilitating
Hdm2-p53 physical interaction (discussed below), wesupport that YY1 stimulation of p53 requires Mdm2 and
that the polyubiquitinated p53 is destined for protea- favor the model that YY1 functions as a cofactor for
Hdm2 to induce p53 polyubiquitination in vivo.some-mediated degradation. Importantly, the YY1 mu-
tant (200–295), which is defective for binding Hdm2,
was significantly compromised in its ability to stimulate YY1 Regulates Hdm2-p53 Physical Interaction
To address the consequence of YY1’s physical interac-p53 ubiquitination both in vitro (Figure 6C, lanes 5–7)
and in vivo (Figure 5B, lane 7). Taken together, these tion with Hdm2, we analyzed the effect of YY1 overex-
pression on the Hdm2-p53 interaction by CoIP. Increas-experiments demonstrated that YY1 is sufficient to in-
duce Hdm2-mediated p53 polyubiquitination in the ab- ing amounts of wt but not the Hdm2 binding-defective
GFP are shown in the lower panel. The reason that no significant decrease of p53 was observed is most likely due to low transfection efficiency
of the WI-38 cells.
(C) YY1 overexpression leads to decreased steady level of endogenous p53. U2OS cells containing tet-off responsive yy1 were first maintained
in medium with 0.5 g/ml of tet. Aliquots of cells were collected at a number of time points as indicated after tet withdrawal, followed by
Western blotting using the antibodies indicated on the left.
(D) YY1 enhances p53 polyubiquitination through K48 of Ub. Myc-epitope tagged wt Ub or the Ub mutant (K48R) were cotransfected with
increased amounts of pcDNA3/yy1 (0, 1.5, and 3.0 g), pCMV/hdm2 (1.5 g), and pCMV/p53 (1.5 g) into U2OS cells. Two days after
transfection, p53 was isolated by IP and analyzed by Western blot using myc-epitope antibody (top panel). The same blot was reprobed with
a p53 monoclonal antibody (middle panel). The direct Western blots for YY1, p53, Hdm2, and cotransfected GFP are shown in the lower
panels. The reason that no significant decrease of p53 level was observed is probably due to overexpression of p53 and saturation of
the proteasome.
(E) YY1 overexpression stimulates Hdm2-mediated p53 ubiquitination. Increasing amounts (indicated on the top) of pcDNA3/yy1 were cotrans-
fected into p53//mdm2/ double knockout MEF cells with plasmids encoding wt Hdm2 or a mutant Hdm2 (C464A), p53, and poly HA-Ub.
p53 was isolated by IP and analyzed by an HA antibody.
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Figure 7. YY1 Regulates Hdm2-p53 Inter-
action
(A) Overexpression of YY1 enhances Hdm2-
p53 interaction. pCMV/hdm2 and pCMV/p53
(2 g of each) were transfected into U2OS
cells with either pcDNA3/HA-yy1 or pcDNA3/
HA-yy1 (200–295) (1.0 and 2.0 g of each).
Hdm2 was coimmunoprecipitated by a p53
antibody (FL-393) and detected by Western
blot using an Hdm2 antibody (Smp-14). Direct
Western blot of the samples used are shown
in the lower panels.
(B) yy1 RNAi decreases the interaction be-
tween Hdm2 and p53. U2OS cells were in-
fected by retroviruses containing U6/gfp
siRNA or U6/yy1 siRNA. Two days after infec-
tion, cells were cotransfected with pCMV/
hdm2 and pCMV/p53 (2.0 g each). Cell ly-
sates were normalized using p53 as the refer-
ence, immunoprecipitated with a p53 anti-
body, and analyzed by Western blot. Direct
Western blot of the samples used are shown
in the lower panels.
YY1 mutant (200–295) caused a reduction in p53 level aa 216–224 of YY1 to be important for the p14ARF interac-
tion (Figure 8B). Given that p14ARF interacts with both YY1(Figure 7A). Importantly, despite the decrease in p53, a
p53 antibody brought down significantly more Hdm2 and Hdm2, we asked whether the Hdm2-YY1 interaction
can be regulated by p14ARF. As shown in Figure 8C,when YY1 was overexpressed (Figure 7A, compare lanes
2 and 3 with lane 1). This stimulatory activity of YY1 the Hdm2-YY1 interaction was significantly impaired by
p14ARF in a dose-dependent manner (top panel, comparewas dependent on YY1 interaction with Hdm2, since
the Hdm2 binding-defective YY1 mutant (200–295) was lanes 2–5 with lane 1). Conversely, overexpression of
YY1 can antagonize the ability of p14ARF to stabilize p53significantly compromised in its ability to stimulate
Hdm2-p53 interaction (Figure 7A, compare lanes 4 and (Figure 8D, compare lane 3 with lane 2). The fact that
p14ARF can disrupt the YY1-Hdm2 interaction lends fur-5 with lane 1). This strongly suggests that wt YY1 pro-
motes Hdm2-p53 physical interaction via a protein-pro- ther support to the idea that the YY1-Hdm2 physical
interaction is likely to be functionally important, and thetein interaction mechanism. Consistently, RNAi knock-
down of YY1 resulted in a decrease in the interaction disruption of this physical interaction by p14ARF may be
an important event during oncogenesis.between Hdm2 and p53 (Figure 7B, top panel). In this
experiment, the immunoprecipitated p53 from the con-
trol and yy1 siRNA-treated cells was normalized to equal Discussion
levels (Figure 7B, top panel), and an equal amount of
Hdm2 was used (Figure 7B, bottom panel). Taken to- We have provided genetic and biochemical evidence
gether, these findings suggest that YY1 is likely to be revealing an essential requirement of YY1 for regulation
required for optimal Hdm2-p53 interaction and p53 ubi- of p53 in vivo. We have shown that knocking out YY1
quitination in vivo. results in a significant increase in p53 level and a reduc-
tion of endogenous p53 ubiquitination (Figures 1C, 2A,
2B, and 5B). Consistently, an increase in YY1 leads toRegulation of YY1-Hdm2 Interaction
by the Tumor Suppressor p14ARF enhanced p53 ubiquitination mediated by Hdm2 both
in vivo and in vitro and a decreased endogenous p53As a tumor surveillance mechanism, p14ARF inactivates
Hdm2 either by relocating it into the nucleolus or by steady-state level (Figures 5 and 6). These findings sug-
gest that YY1 regulates p53 through modulation of theforming a tripartite complex with Hdm2 and p53, which
prevents p53 export and degradation (reviewed in Zhang ability of Hdm2 to ubiquitinate p53. Our findings further
suggest that this newly identified YY1 function is inde-and Xiong [2001]). Given the findings discussed above,
we wished to investigate whether p14ARF also interacts pendent of its transcriptional activity. Instead, strong
evidence is provided that supports the model of YY1with YY1 and regulates the physical and functional inter-
action of YY1 with Hdm2-p53. As shown in Figure 8A, regulation of Hdm2-p53 via direct protein-protein inter-
actions. First, similar to the wt protein, the YY1 mutantCoIP experiments identified physical interactions be-
tween endogenous p14ARF and YY1 in the p14ARF- that is unable to recognize YY1 consensus sites and
therefore presumed to be defective in activating or re-expressing HeLa cells. This interaction is likely to be
direct, since bacterially purified YY1 can also interact pressing YY1 target genes can still stimulate p53 ubiqui-
tination (Figure 5B). Second, YY1 physically interactswith the in vitro translated p14ARF (Figure 8B). We next
carried out domain mapping experiments and identified with Hdm2 and p53 in vivo and can directly bind these
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Figure 8. p14ARF Regulation of YY1-Hdm2 Interaction
(A) YY1 interacts with p14ARF in vivo. HeLa cell lysates were respectively incubated with GFP, -gal, and p14ARF antibodies for immunoprecipitation
and Western blotted with YY1 (top panel) and p14ARF antibody (bottom panel).
(B) Identification of a p14ARF-interacting domain in YY1. GST-YY1 fusion proteins are diagramed in the top panel. The purified GST-YY1 proteins
(3 g each) were incubated with in vitro translated p14ARF labeled by 35S-methionine, followed by SDS-PAGE analysis. The autoradiography
and the Coomassie blue staining of input GST fusion proteins are shown in the middle and the lower panels, respectively. The interaction
results are summarized on the right of the diagram, and the interacting domains for p53, Hdm2, and p14ARF are indicated at the top.
(C) Overexpression of p14ARF disrupts Hdm2-YY1 interaction. Equal amounts of pcDNA3/yy1 and pCMV/hdm2, together with increasing amounts
of pcDNA3/HA-p14ARF, were cotransfected to HeLa cells (indicated on the top). A YY1 antibody (H-414) was used to CoIP Hdm2. The top
panels show the immunoprecipitated Hdm2 and YY1 in the presence of increasing amounts of p14ARF. Direct Western blots for Hdm2 and
cotransfected GFP are shown in the bottom panels.
(D) Overexpression of YY1 can antagonize the ability of p14ARF to stabilize p53. U2OS cells containing tet-off responsive yy1 were cultured in
the presence of tet to suppress expression of the tet-off yy1 transgene prior to transfection with 4 g of pcDNA3 vector (lane 1) or pcDNA/
HA-p14ARF (lanes 2 and 3). The cells were then grown in medium with (lanes 1 and 2) or without 0.5 g/ml of tet (lane 3). Thirty-six hours
posttransfection, cells were collected and analyzed by Western blot using the antibodies indicated on the left.
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two proteins in vitro (Figure 4). Significantly, the Hdm2 nation, suggesting that recruitment of HDAC1 is not the
binding-defective YY1 is compromised in its ability to main mechanism by which YY1 promotes p53 ubiquiti-
promote p53 ubiquitination, substantiating the func- nation (our unpublished data). Alternatively, since YY1
tional importance of the physical interaction (Figure 5B). interacts with p300 (Lee et al., 1995a), which has recently
Third, wt recombinant YY1 but not the Hdm2 binding- been shown to function as an E4 ligase for p53 polyubi-
defective mutant induces p53 polyubiquitination in an quitination (Grossman et al., 2003), it is also possible
in vitro ubiquitination system (Figure 6). Taken together, that YY1 may recruit p300 to promote p53 ubiquitination.
these results strongly support direct protein-protein in- Our in vitro ubiquitination result shows, however, that
teractions as a mechanism by which YY1 regulates p53 YY1 is sufficient to promote p53 ubiquitination without
in vivo. These findings, however, do not exclude the p300 (Figure 6). Lastly, it is possible that additional post-
possibility that the functional interaction between YY1 translational modifications of Hdm2 and/or p53 may
and Hdm2-p53 could occur on DNA. Our recent microar- take place in the absence of YY1 that could contribute
ray data suggest that YY1 regulates a large number of to the regulation of the Hdm2-p53 interaction.
p53 target genes (our unpublished data). Future experi- We also investigated whether blocking p53 expres-
ments will determine whether these genes are direct sion can rescue cell death or growth arrest caused by the
targets for both YY1 and p53 and whether YY1 may loss of YY1. Preliminary results show that simultaneous
promote p53 ubiquitination and degradation on pro- inhibition of YY1 and p53 expression by RNAi failed to
moters. rescue the YY1 depletion phenotype (our unpublished
How, then, does YY1 promote p53 ubiquitination via data). This is perhaps not surprising, because YY1 may
physical interactions? We have shown that overexpres- play multiple roles in cells, including the well-established
sion of wt but not the Hdm2 binding-defective YY1 re- transcription function. Our recent microarray results
sults in a dose-dependent increase in the physical inter- suggest that YY1 not only regulates p53 target genes
action between Hdm2 and p53. Consistently, a reduction but also genes involved in cell cycle progression, mito-
of YY1 level leads to a decrease in Hdm2-p53 interac- sis, and differentiation (our unpublished data), thus of-
tion. Previous studies of the Hdm2-interacting protein fering a possible molecular explanation for the failure
p14ARF (p19ARF for the mouse homolog) suggest that of the rescue experiments discussed above.
p14ARF can inactivate Hdm2 by relocalizing it to the nu- Taken together, our findings uncovered a crucial role
cleolus under certain circumstances (Weber et al., 1999). for YY1 in controlling p53 homeostasis via regulating
However, depletion of YY1 did not cause Hdm2 relocal- Hdm2-mediated p53 ubiquitination through a direct
ization under our assay conditions (our unpublished physical interaction mechanism. The physical interac-
data). Since YY1 can interact with both Hdm2 and p53 tion of YY1 with Hdm2 appears to be important for effi-
to form a ternary complex (Supplemental Figure S6), we cient Hdm2-p53 interaction in vivo, which in turn is nec-
speculate that YY1 probably helps stabilize the physical essary for p53 ubiquitination. These findings highlight
interaction between Hdm2 and p53 in vivo. Consistent the complexity of the Hdm2-p53 ubiquitination process
with this, as revealed by the YY1 spacer mutant (200– in vivo and support the emerging paradigm that p53
295) that binds p53 but is compromised in its ability to ubiquitination and degradation are subjected to regula-
interact with Hdm2, YY1 binding to p53 alone is not tion at multiple levels via both direct and indirect mecha-
sufficient for YY1 to promote p53 ubiquitination or effi- nisms. Furthermore, these findings suggest that alter-
cient Hdm2-p53 physical interaction (Figures 5B, 6C, ation of YY1 expression and/or activity may be an
and 7A). A recent report suggests that Hdm2 at a high important event during oncogenesis. Consistent with
concentration is sufficient to mediate p53 polyubiquiti- this hypothesis, YY1 expression is found to be elevated
nation, but, at a low concentration, Hdm2 only monoubi- in tumors such as lung adenocarcinoma (our unpub-
quitinates p53 (Li et al., 2003). Based on this model, we lished data) and some cases of human acute myeloid
speculate that, by enhancing the Hdm2-p53 interaction,
leukemia (Erkeland et al., 2003). The finding that p14ARF
YY1 may have increased the effective local concentra-
can disrupt Hdm2-YY1 interaction (Figure 8C), which is
tion of Hdm2, thus enabling Hdm2 to mediate p53 poly-
important for efficient polyubiquitination of p53 medi-ubiquitination. Taken together, these findings suggest
ated by Hdm2 (Figure 5), further supports a role for YY1that YY1 is essential for optimal Hdm2-p53 physical
in tumorigenesis.interaction in vivo, which is a prerequisite for Hdm2 to
be able to ubiquitinate p53.
Experimental ProceduresIn addition to the physical interaction model for YY1
regulation of Hdm2-p53 interaction discussed above, Cell Culture
other mutually nonexclusive possibilities must also be Standard conditions and procedures were used for culturing mam-
considered. For instance, previous studies showed that malian and DT40 cells, respectively (Sambrook et al., 1990; Wang
et al., 1996).p53 stability can be regulated by various posttransla-
tional modifications such as phosphorylation and acety-
lation (Ito et al., 2002; Prives, 1998). Deacetylation of Plasmids
A human yy1 zinc finger probe was used to isolate a chicken yy1p53 by HDAC1 has been shown to facilitate p53 ubiquiti-
cDNA, which was then used to obtain cyy1 genomic fragments fromnation and degradation (Ito et al., 2002). Since YY1 inter-
a chicken spleen genomic library (Stratagene). The tTA plasmid wasacts with HDAC1 (Yang et al., 1996), it is possible that
from J. Manley. The tet-repressive cyy1 plasmid was constructed
YY1 may be targeting HDAC1 to the Hdm2-p53 complex using pUHD/10-3 (Gossen and Bujard, 1992) with the Kozak se-
for p53 modification. However, we found that the HDAC quence altered from AAC to TTC to dampen cYY1 expression.
binding-defective YY1 (Yang et al., 1996) had compara- pcDNA3/yy1 (200–295) was constructed by PCR-based mutagene-
sis. Mutant GST-p53 and GST-Hdm2 are from W. Gu, while otherble activity in stimulating Hdm2-mediated p53 ubiquiti-
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GST- and His-fusion plasmids were generated in this lab. pCMV/ NRSA from the NCI (F32CA097802). This work was supported by a
grant from the NIH (GM53874) (to Yang Shi).p53, pCMV/hdm2, pCMV/hdm2 (C464A), pcDNA3/poly HA-Ub, and
pcDNA3/HA-p14ARF are from Y. Xiong. BS/U6 yy1 and gfp siRNA
vectors were constructed as described (Sui et al., 2002). The se- Received: October 16, 2003
quences of yy1 and the gfp siRNAs are 5-GGGAGCAGAAGCAG Revised: April 20, 2004
GUGCAGAU-3 and 5-GGGCCAUGGCACGUACGGCAAG-3. Accepted: April 23, 2004
Published: June 24, 2004
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